Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Blood and Marrow Transplantation (BMT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00427765
What this trial is testing

Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma
M.D. Anderson Cancer Center 168
Testing effectiveness (Phase 2)Study completedNCT00186394
What this trial is testing

High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinBlood and Marrow Transplant (BMT)Lymphomas: Non-Hodgkin
Stanford University 35
Large-scale testing (Phase 3)UnknownNCT00998270
What this trial is testing

Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Tehran University of Medical Sciences 185
Large-scale testing (Phase 3)Looking for participantsNCT07702578
What this trial is testing

T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
AMLMDS
TScan Therapeutics, Inc. 310
Large-scale testing (Phase 3)Study completedNCT00075803
What this trial is testing

Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)

Who this might be right for
LymphomaInfectionLeukemia
Medical College of Wisconsin 600
Not applicableStudy completedNCT00507260
What this trial is testing

Nutritional Assessment Intervention to Improve Cancer-Related Fatigue

Who this might be right for
LeukemiaLymphomaFatigue
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT01860170
What this trial is testing

Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis

Who this might be right for
Hematological Malignancy
Corewell Health West 28
Not applicableStudy completedNCT00281814
What this trial is testing

Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 36
Not applicableStudy completedNCT00186576
What this trial is testing

Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders

Who this might be right for
Myelodysplastic SyndromesMyeloproliferative DisordersBlood and Marrow Transplant (BMT)+2 more
Stanford University 40
Early research (Phase 1)Looking for participantsNCT05473910
What this trial is testing

T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
AMLMDS
TScan Therapeutics, Inc. 310
Testing effectiveness (Phase 2)Study completedNCT00813124
What this trial is testing

Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

Who this might be right for
Stem Cell TransplantationLeukemia
M.D. Anderson Cancer Center 24
Very early researchStudy completedNCT01174940
What this trial is testing

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

Who this might be right for
Stem Cell Leukemia of Unclear LineageGraft Versus Host Disease
University of Kansas Medical Center 22
Testing effectiveness (Phase 2)Ended earlyNCT00167180
What this trial is testing

Post Transplant Donor Lymphocyte Infusion

Who this might be right for
Leukemia, Myeloid, ChronicLymphomasMultiple Myeloma+4 more
Masonic Cancer Center, University of Minnesota 57
Large-scale testing (Phase 3)UnknownNCT02270307
What this trial is testing

MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis

Who this might be right for
LeukemiaMultiple Myeloma
National Research Center for Hematology, Russia 40